Magnetic Resonance - Technology Information Portal Welcome to MRI Technology•
Info
  Sheets

Out-
      side
 
 
 'Magnevist® Enteral' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Magnevist® Enteral' found in 1 term [] and 1 definition []
1 - 2 (of 2)     
Result Pages : [1]
MRI Resources 
Spectroscopy pool - Implant and Prosthesis pool - Chemistry - Abdominal Imaging - Sequences - Health
 
Magnevist® EnteralInfoSheet: - Contrast Agents - Intro, Overview, Characteristics, Types of, etc.MRI Resource Directory: - Contrast Agents -
 
Magnevist® enteral (Gadopentetate) is a Gd-DTPA solution for use as a gastrointestinal contrast agent to visualize the bowel in MRI scans.

See also Positive Oral Contrast Agents and Gadopentetate Gastrointestinal.
Drug Information and Specification
NAME OF COMPOUND
Gadopentetate dimeglumine, Gd-DTPA
DEVELOPER
Bayer Schering Pharma AG
CENTRAL MOIETY
Gd3+
CONTRAST EFFECT
T1, Predominantly positive enhancement
RELAXIVITY
Paramagnetic
PHARMACOKINETIC
Gastrointestinal
OSMOLALITY
CONCENTRATION
0.001 mol/L
DOSAGE
100 ml oral
PREPARATION
Finished product
INDICATION
Bowel marking
DEVELOPMENT STAGE
For sale
DISTRIBUTOR
See below
PRESENTATION
Vial of 100 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT
STAGE
DISTRIBUTOR
USA
Magnevist® enteral
for sale
Bayer HealthCare Pharmaceuticals
EU
Magnevist® enteral
for sale
Bayer Schering Pharma AG
spacer
 
• Share the entry 'Magnevist® Enteral':  Facebook  Twitter  LinkedIn  
MRI Resources 
Absorption and Emission - Stent - Fluorescence - Manufacturers - Hospitals - Jobs pool
 
Bayer Schering Pharma AGMRI Resource Directory: - Manufacturers -
 
www.bayerscheringpharma.de/scripts/pages/en/index.php The Germany-based pharmaceutical company is the result of the take-over of Schering AG by Bayer AG in 2006. The Bayer Schering Pharma AG is part of the Bayer HealthCare AG, which represents the pharmaceutical part of the Bayer Group. Activities of the Bayer Schering Pharma AG are Diagnostic Imaging, Hematology and Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. The diagnostic imaging part's contrast agents for MRI, x-ray and computed tomography are 'world-market leaders'.

MRI Contrast Agents:
•
Magnevist® enteral
•
Magnevist®
•
Gadovist®
•
Resovist®
•
Primovist™,Eovist®
•
Vasovist®
•
Gadofluorine
•
Gadophrin
•
Gadomer 17
•
Gd-DTPA-Polylysine
•
Supravist™
Contact Information
MAIL
Bayer Schering Pharma AG
51368 Leverkusen
GERMANY
PHONE
+49-30-46-81-2431
FAX
+49-30-46-81-8195
ONLINE
www.bayerscheringpharma.de/scripts/pages/en/index.php
spacer

• View the DATABASE results for 'Bayer Schering Pharma AG' (22).Open this link in a new window


• View the NEWS results for 'Bayer Schering Pharma AG' (25).Open this link in a new window.
 
Further Reading:
  News & More:
Drastic market changes with MRI contrast media and PET radiopharmaceuticals emerging as most promising segments
Thursday, 21 October 2004   by www.news-medical.net    
Epix Pharmaceuticals to shut down
Tuesday, 21 July 2009   by boston.bizjournals.com    
MRI Resources 
Shielding - Claustrophobia - Sequences - Services and Supplies - Stimulator pool - Stent
 
     1 - 2 (of 2)     
Result Pages : [1]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



MRI is trending to low field magnets :
reduced costs will lead to this change 
AI will close the gap to high field 
only in remote areas 
is only temporary 
never 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 18 December 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]